264 related articles for article (PubMed ID: 20071094)
1. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
Arya SC; Agarwal N; Agarwal S
Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
[No Abstract] [Full Text] [Related]
2. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
[No Abstract] [Full Text] [Related]
3. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S
Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility and ESBL prevalence in Pseudomonas aeruginosa isolated from burn patients in the North West of Pakistan.
Ullah F; Malik SA; Ahmed J
Burns; 2009 Nov; 35(7):1020-5. PubMed ID: 19501980
[TBL] [Abstract][Full Text] [Related]
5. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
Wang C; Cai P; Chang D; Mi Z
J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
[No Abstract] [Full Text] [Related]
6. [Wound infection of Pseudomonas etiology in traumatology and orthopedic patients].
Sheina EP; Ruindezh TG; Arutcheva AA
Ortop Travmatol Protez; 1979 Aug; (8):7-11. PubMed ID: 116182
[No Abstract] [Full Text] [Related]
7. [Treatment of Pseudomonas aeruginosa infection in burn patients].
Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
[No Abstract] [Full Text] [Related]
8. [Analysis of susceptibility of Pseudomonas aeruginosa isolated from a burn ward to antibiotics in vitro].
Zhang YH; Deng SL; Liu JW
Zhonghua Shao Shang Za Zhi; 2005 Apr; 21(2):104-6. PubMed ID: 15938955
[TBL] [Abstract][Full Text] [Related]
9. [Antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with infected burns].
Adarchenko AA; Zmushko LS; Kostrova NA; Kots NK
Antibiotiki; 1980 Aug; 25(8):576-9. PubMed ID: 6773473
[TBL] [Abstract][Full Text] [Related]
10. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
[TBL] [Abstract][Full Text] [Related]
11. Serotyping, sites of isolation and resistance of Pseudomonas aeruginosa.
Dette GA; Knothe H; Schäfer V; Pirlet-Berninger U
Microbiologica; 1988 Apr; 11(2):129-35. PubMed ID: 3136301
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa.
Mullai V; Menon T
J Altern Complement Med; 2007 May; 13(4):439-41. PubMed ID: 17532737
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Coetzee E; Rode H; Kahn D
S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-microbiologic aspects of burns complicated by suppurative infection].
Znamenskiĭ VA; Litovchenko PP; Degtiar NV; Sitniakovskaia VS; Chernobrovyĭ NP
Khirurgiia (Mosk); 1989 Mar; (3):115-7. PubMed ID: 2724836
[No Abstract] [Full Text] [Related]
15. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections.
Haghi F; Zeighami H; Monazami A; Toutouchi F; Nazaralian S; Naderi G
Microb Pathog; 2018 Feb; 115():251-256. PubMed ID: 29273509
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
Supp DM; Gardner J; Klingenberg JM; Neely AN
Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
[TBL] [Abstract][Full Text] [Related]
18. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
Prasad SV; Ballal M; Shivananda PG
Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
[TBL] [Abstract][Full Text] [Related]
19. [Biological properties of Pseudomonas aeruginosa strains isolated from surgical and burn wounds of hospitalized patients].
Maresz-Babczyszyn J; Sokalska M; Popiel D
Med Dosw Mikrobiol; 1979; 31(4):217-23. PubMed ID: 120914
[No Abstract] [Full Text] [Related]
20. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran.
Khosravi AD; Mihani F
Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
